 | | V9A | | Name: | N-{5-[4-(2-amino-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-6-yl)butyl]furan-2-carbonyl}-L-glutamic acid | | Formula: | C20 H22 N4 O7 S | | SMILES: | OC(CCC(C(O)=O)NC(=O)c3ccc(CCCCc1cc2c(s1)N=C(N)NC2=O)o3)=O | | InChi: | InChI=1S/C20H22N4O7S/c21-20-23-16(27)12-9-11(32-18(12)24-20)4-2-1-3-10-5-7-14(31-10)17(28)22-13(19(29)30)6-8-15(25)26/h5,7,9,13H,1-4,6,8H2,(H,22,28)(H,25,26)(H,29,30)(H3,21,23,24,27)/t13-/m0/s1 | | Definition date: | 2020-07-20 | | Last modified: | 2021-03-26 | | Release date: | 2021-03-31 | | Identifier: | N-{5-[4-(2-amino-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-6-yl)butyl]furan-2-carbonyl}-L-glutamic acid |
|
 | | V9V | | Name: | N-(5-{3-[(1S,7R,8R,9S)-4-amino-2-oxo-7lambda~4~-thia-3,5-diazatetracyclo[4.3.0.0~1,7~.0~7,9~]nona-3,5-dien-8-yl]propyl}thiophene-2-carbonyl)-L-glutamic acid | | Formula: | C19 H20 N4 O6 S2 | | SMILES: | c21C(NC(=Nc1sc(c2)CCCc3ccc(C(NC(CCC(=O)O)C(=O)O)=O)s3)N)=O | | InChi: | InChI=1S/C19H20N4O6S2/c20-19-22-15(26)11-8-10(31-17(11)23-19)3-1-2-9-4-6-13(30-9)16(27)21-12(18(28)29)5-7-14(24)25/h4,6,8,12H,1-3,5,7H2,(H,21,27)(H,24,25)(H,28,29)(H3,20,22,23,26)/t12-/m0/s1 | | Definition date: | 2020-07-21 | | Last modified: | 2021-03-26 | | Release date: | 2021-03-31 | | Identifier: | N-{5-[3-(2-amino-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-6-yl)propyl]thiophene-2-carbonyl}-L-glutamic acid |
|
 | | YNJ | | Name: | 7-{[(2S)-2-butyl-6,7-dichloro-2-cyclopentyl-1-oxo-2,3-dihydro-1H-inden-5-yl]oxy}heptanoic acid | | Formula: | C25 H34 Cl2 O4 | | SMILES: | O=C(O)CCCCCCOc1cc2CC(CCCC)(C(=O)c2c(Cl)c1Cl)C1CCCC1 | | InChi: | InChI=1S/C25H34Cl2O4/c1-2-3-13-25(18-10-7-8-11-18)16-17-15-19(22(26)23(27)21(17)24(25)30)31-14-9-5-4-6-12-20(28)29/h15,18H,2-14,16H2,1H3,(H,28,29)/t25-/m0/s1 | | Definition date: | 2021-03-15 | | Last modified: | 2021-03-19 | | Release date: | 2021-03-24 | | Identifier: | 7-{[(2S)-2-butyl-6,7-dichloro-2-cyclopentyl-1-oxo-2,3-dihydro-1H-inden-5-yl]oxy}heptanoic acid |
|
 | | YO7 | | Name: | [(2R,3S,4R,5R)-5-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl (2R,3S,4R,5R,6S)-6-[(1R)-1,2-dihydroxyethyl]-3,4,5-trihydroxyoxan-2-yl dihydrogen diphosphate (non-preferred name) | | Formula: | C17 H27 N5 O17 P2 | | SMILES: | NC1=Nc2c(ncn2C2OC(COP(=O)(O)OP(=O)(O)OC3OC(C(O)C(O)C3O)C(O)CO)C(O)C2O)C(=O)N1 | | InChi: | InChI=1S/C17H27N5O17P2/c18-17-20-13-6(14(30)21-17)19-3-22(13)15-10(28)7(25)5(36-15)2-35-40(31,32)39-41(33,34)38-16-11(29)8(26)9(27)12(37-16)4(24)1-23/h3-5,7-12,15-16,23-29H,1-2H2,(H,31,32)(H,33,34)(H3,18,20,21,30)/t4-,5-,7-,8-,9-,10-,11+,12+,15-,16-/m1/s1 | | Definition date: | 2021-03-16 | | Last modified: | 2021-03-19 | | Release date: | 2021-03-24 | | Identifier: | [(2R,3S,4R,5R)-5-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl (2R,3S,4R,5R,6S)-6-[(1R)-1,2-dihydroxyethyl]-3,4,5-trihydroxyoxan-2-yl dihydrogen diphosphate (non-preferred name) |
|
 | | XBA | | Name: | 7-(cyclopropylmethoxy)-5-fluoro-2-{[(trans-4-hydroxycyclohexyl)sulfanyl]methyl}quinazolin-4(3H)-one | | Formula: | C19 H23 F N2 O3 S | | SMILES: | C1CC(CCC1SCC3=Nc2cc(cc(c2C(N3)=O)F)OCC4CC4)O | | InChi: | InChI=1S/C19H23FN2O3S/c20-15-7-13(25-9-11-1-2-11)8-16-18(15)19(24)22-17(21-16)10-26-14-5-3-12(23)4-6-14/h7-8,11-12,14,23H,1-6,9-10H2,(H,21,22,24)/t12-,14- | | Definition date: | 2020-12-08 | | Last modified: | 2021-03-19 | | Release date: | 2021-03-24 | | Identifier: | 7-(cyclopropylmethoxy)-5-fluoro-2-{[(trans-4-hydroxycyclohexyl)sulfanyl]methyl}quinazolin-4(3H)-one |
|
 | | HUF | | Name: | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2R,3S,4S)-5-[5-methanoyl-7,8-dimethyl-2,4-bis(oxidanylidene)-1H-benzo[g]pteridin-10-yl]-2,3,4-tris(oxidanyl)pentyl] hydrogen phosphate | | Formula: | C28 H35 N9 O16 P2 | | SMILES: | Cc1cc2N(C[CH](O)[CH](O)[CH](O)CO[P](O)(=O)O[P](O)(=O)OC[CH]3O[CH]([CH](O)[CH]3O)n4cnc5c(N)ncnc45)C6=C(N(C=O)c2cc1C)C(=O)NC(=O)N6 | | InChi: | InChI=1S/C28H35N9O16P2/c1-11-3-13-14(4-12(11)2)37(10-38)19-25(33-28(45)34-26(19)44)35(13)5-15(39)20(41)16(40)6-50-54(46,47)53-55(48,49)51-7-17-21(42)22(43)27(52-17)36-9-32-18-23(29)30-8-31-24(18)36/h3-4,8-10,15-17,20-22,27,39-43H,5-7H2,1-2H3,(H,46,47)(H,48,49)(H2,29,30,31)(H2,33,34,44,45)/t15-,16+,17+,20-,21+,22+,27+/m0/s1 | | Definition date: | 2021-02-02 | | Last modified: | 2021-03-19 | | Release date: | 2021-03-24 | | Identifier: | [[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{R},3~{S},4~{S})-5-[5-methanoyl-7,8-dimethyl-2,4-bis(oxidanylidene)-1~{H}-benzo[g]pteridin-10-yl]-2,3,4-tris(oxidanyl)pentyl] hydrogen phosphate |
|
 | | WJV | | Name: | N-[2-(3,3-dimethylbutoxy)ethyl]-N'-{4-methyl-5-[(pyridin-4-yl)ethynyl]-1,3-thiazol-2-yl}urea | | Formula: | C20 H26 N4 O2 S | | SMILES: | Cc1nc(NC(NCCOCCC(C)(C)C)=O)sc1C#Cc2ccncc2 | | InChi: | InChI=1S/C20H26N4O2S/c1-15-17(6-5-16-7-10-21-11-8-16)27-19(23-15)24-18(25)22-12-14-26-13-9-20(2,3)4/h7-8,10-11H,9,12-14H2,1-4H3,(H2,22,23,24,25) | | Definition date: | 2020-10-30 | | Last modified: | 2021-03-19 | | Release date: | 2021-03-24 | | Identifier: | N-[2-(3,3-dimethylbutoxy)ethyl]-N'-{4-methyl-5-[(pyridin-4-yl)ethynyl]-1,3-thiazol-2-yl}urea |
|
 | | W97 | | Name: | 6-ethynyl-1-(pentan-3-yl)-1H-imidazo[4,5-b]pyrazin-2-ol | | Formula: | C12 H14 N4 O | | SMILES: | C#Cc1cnc2c(n1)n(c(n2)O)C(CC)CC | | InChi: | InChI=1S/C12H14N4O/c1-4-8-7-13-10-11(14-8)16(12(17)15-10)9(5-2)6-3/h1,7,9H,5-6H2,2-3H3,(H,13,15,17) | | Definition date: | 2020-10-01 | | Last modified: | 2021-03-19 | | Release date: | 2021-03-24 | | Identifier: | 6-ethynyl-1-(pentan-3-yl)-1H-imidazo[4,5-b]pyrazin-2-ol |
|
 | | R7B | | Name: | 8-cyclohexyl-6~{H}-imidazo[1,2-c]pyrimidin-5-one | | Formula: | C12 H15 N3 O | | SMILES: | O=C1NC=C(C2CCCCC2)c3nccn13 | | InChi: | InChI=1S/C12H15N3O/c16-12-14-8-10(9-4-2-1-3-5-9)11-13-6-7-15(11)12/h6-9H,1-5H2,(H,14,16) | | Definition date: | 2020-09-14 | | Last modified: | 2021-03-19 | | Release date: | 2021-03-24 | | Identifier: | 8-cyclohexyl-6~{H}-imidazo[1,2-c]pyrimidin-5-one |
|
 | | R7K | | Name: | ~{N}-[[2,4-bis(fluoranyl)phenyl]methyl]-5-(hydroxymethyl)-1,4-bis(oxidanyl)-2-oxidanylidene-1,8-naphthyridine-3-carboxamide | | Formula: | C17 H13 F2 N3 O5 | | SMILES: | OCc1ccnc2N(O)C(=O)C(=C(O)c12)C(=O)NCc3ccc(F)cc3F | | InChi: | InChI=1S/C17H13F2N3O5/c18-10-2-1-8(11(19)5-10)6-21-16(25)13-14(24)12-9(7-23)3-4-20-15(12)22(27)17(13)26/h1-5,23-24,27H,6-7H2,(H,21,25) | | Definition date: | 2020-09-17 | | Last modified: | 2021-03-19 | | Release date: | 2021-03-24 | | Identifier: | ~{N}-[[2,4-bis(fluoranyl)phenyl]methyl]-5-(hydroxymethyl)-1,4-bis(oxidanyl)-2-oxidanylidene-1,8-naphthyridine-3-carboxamide |
|
 | | R7N | | Name: | 4-azanyl-~{N}-[[2,4-bis(fluoranyl)phenyl]methyl]-6-[2-(2-morpholin-4-ylethylsulfonyl)ethyl]-1-oxidanyl-2-oxidanylidene-1,8-naphthyridine-3-carboxamide | | Formula: | C24 H27 F2 N5 O6 S | | SMILES: | NC1=C(C(=O)NCc2ccc(F)cc2F)C(=O)N(O)c3ncc(CC[S](=O)(=O)CCN4CCOCC4)cc13 | | InChi: | InChI=1S/C24H27F2N5O6S/c25-17-2-1-16(19(26)12-17)14-29-23(32)20-21(27)18-11-15(13-28-22(18)31(34)24(20)33)3-9-38(35,36)10-6-30-4-7-37-8-5-30/h1-2,11-13,34H,3-10,14,27H2,(H,29,32) | | Synonyms: | INSTI XZ447 | | Definition date: | 2020-09-17 | | Last modified: | 2021-03-19 | | Release date: | 2021-03-24 | | Identifier: | 4-azanyl-~{N}-[[2,4-bis(fluoranyl)phenyl]methyl]-6-[2-(2-morpholin-4-ylethylsulfonyl)ethyl]-1-oxidanyl-2-oxidanylidene-1,8-naphthyridine-3-carboxamide |
|
 | | P8W | | Name: | 2,4-dimethyl-5-[(2-phenylphenyl)methylamino]pyridazin-3-one | | Formula: | C19 H19 N3 O | | SMILES: | CN1N=CC(=C(C)C1=O)NCc2ccccc2c3ccccc3 | | InChi: | InChI=1S/C19H19N3O/c1-14-18(13-21-22(2)19(14)23)20-12-16-10-6-7-11-17(16)15-8-4-3-5-9-15/h3-11,13,20H,12H2,1-2H3 | | Synonyms: | Biphenyl-methylamino-dimethylpyridazinone | | Definition date: | 2020-04-18 | | Last modified: | 2021-03-19 | | Release date: | 2021-03-24 | | Identifier: | 2,4-dimethyl-5-[(2-phenylphenyl)methylamino]pyridazin-3-one |
|
 | | P8Z | | Name: | 2,4-dimethyl-5-[[2-(4-methylpiperazin-1-yl)phenyl]methylamino]pyridazin-3-one | | Formula: | C18 H25 N5 O | | SMILES: | CN1CCN(CC1)c2ccccc2CNC3=C(C)C(=O)N(C)N=C3 | | InChi: | InChI=1S/C18H25N5O/c1-14-16(13-20-22(3)18(14)24)19-12-15-6-4-5-7-17(15)23-10-8-21(2)9-11-23/h4-7,13,19H,8-12H2,1-3H3 | | Synonyms: | dimethyl-methylpiperazinyl-benzyl-aminopyridazinone | | Definition date: | 2020-04-18 | | Last modified: | 2021-03-19 | | Release date: | 2021-03-24 | | Identifier: | 2,4-dimethyl-5-[[2-(4-methylpiperazin-1-yl)phenyl]methylamino]pyridazin-3-one |
|
 | | SYW | | Name: | (R)-6-((2-methyl-4-(1-methyl-1H-indole-5-carbonyl)piperazin-1-yl)sulfonyl)benzo[d]oxazol-2(3H)-one | | Formula: | C22 H22 N4 O5 S | | SMILES: | C[CH]1CN(CCN1[S](=O)(=O)c2ccc3NC(=O)Oc3c2)C(=O)c4ccc5n(C)ccc5c4 | | InChi: | InChI=1S/C22H22N4O5S/c1-14-13-25(21(27)16-3-6-19-15(11-16)7-8-24(19)2)9-10-26(14)32(29,30)17-4-5-18-20(12-17)31-22(28)23-18/h3-8,11-12,14H,9-10,13H2,1-2H3,(H,23,28)/t14-/m1/s1 | | Synonyms: | 6-[(2~{R})-2-methyl-4-(1-methylindol-5-yl)carbonyl-piperazin-1-yl]sulfonyl-3~{H}-1,3-benzoxazol-2-one | | Definition date: | 2020-12-08 | | Last modified: | 2021-03-19 | | Release date: | 2021-03-24 | | Identifier: | 6-[(2~{R})-2-methyl-4-(1-methylindol-5-yl)carbonyl-piperazin-1-yl]sulfonyl-3~{H}-1,3-benzoxazol-2-one |
|
 | | S2Q | | Name: | 3-propan-2-yl-~{N}-[(1~{R})-1-(3-sulfamoylphenyl)ethyl]-[1,2]oxazolo[5,4-b]pyridine-5-carboxamide | | Formula: | C18 H20 N4 O4 S | | SMILES: | CC(C)c1noc2ncc(cc12)C(=O)N[CH](C)c3cccc(c3)[S](N)(=O)=O | | InChi: | InChI=1S/C18H20N4O4S/c1-10(2)16-15-8-13(9-20-18(15)26-22-16)17(23)21-11(3)12-5-4-6-14(7-12)27(19,24)25/h4-11H,1-3H3,(H,21,23)(H2,19,24,25)/t11-/m1/s1 | | Definition date: | 2020-11-06 | | Last modified: | 2021-03-19 | | Release date: | 2021-03-24 | | Identifier: | 3-propan-2-yl-~{N}-[(1~{R})-1-(3-sulfamoylphenyl)ethyl]-[1,2]oxazolo[5,4-b]pyridine-5-carboxamide |
|
 | | S2W | | Name: | ~{N}-[(1~{R})-1-[3-azanyl-5-(trifluoromethyl)phenyl]ethyl]-2-methyl-quinazolin-4-amine | | Formula: | C18 H17 F3 N4 | | SMILES: | C[CH](Nc1nc(C)nc2ccccc12)c3cc(N)cc(c3)C(F)(F)F | | InChi: | InChI=1S/C18H17F3N4/c1-10(12-7-13(18(19,20)21)9-14(22)8-12)23-17-15-5-3-4-6-16(15)24-11(2)25-17/h3-10H,22H2,1-2H3,(H,23,24,25)/t10-/m1/s1 | | Definition date: | 2020-11-06 | | Last modified: | 2021-03-19 | | Release date: | 2021-03-24 | | Identifier: | ~{N}-[(1~{R})-1-[3-azanyl-5-(trifluoromethyl)phenyl]ethyl]-2-methyl-quinazolin-4-amine |
|
 | | S2Z | | Name: | 6,7-dimethoxy-2-methyl-~{N}-[(1~{R})-1-phenylethyl]quinazolin-4-amine | | Formula: | C19 H21 N3 O2 | | SMILES: | COc1cc2nc(C)nc(N[CH](C)c3ccccc3)c2cc1OC | | InChi: | InChI=1S/C19H21N3O2/c1-12(14-8-6-5-7-9-14)20-19-15-10-17(23-3)18(24-4)11-16(15)21-13(2)22-19/h5-12H,1-4H3,(H,20,21,22)/t12-/m1/s1 | | Definition date: | 2020-11-06 | | Last modified: | 2021-03-19 | | Release date: | 2021-03-24 | | Identifier: | 6,7-dimethoxy-2-methyl-~{N}-[(1~{R})-1-phenylethyl]quinazolin-4-amine |
|
 | | S3Q | | Name: | 6,7-dimethoxy-2-methyl-~{N}-[(1~{R})-1-[3-(trifluoromethyl)phenyl]ethyl]quinazolin-4-amine | | Formula: | C20 H20 F3 N3 O2 | | SMILES: | COc1cc2nc(C)nc(N[CH](C)c3cccc(c3)C(F)(F)F)c2cc1OC | | InChi: | InChI=1S/C20H20F3N3O2/c1-11(13-6-5-7-14(8-13)20(21,22)23)24-19-15-9-17(27-3)18(28-4)10-16(15)25-12(2)26-19/h5-11H,1-4H3,(H,24,25,26)/t11-/m1/s1 | | Definition date: | 2020-11-06 | | Last modified: | 2021-03-19 | | Release date: | 2021-03-24 | | Identifier: | 6,7-dimethoxy-2-methyl-~{N}-[(1~{R})-1-[3-(trifluoromethyl)phenyl]ethyl]quinazolin-4-amine |
|
 | | S3T | | Name: | ~{N}-[(1~{R})-1-(3-aminophenyl)ethyl]-6,7-dimethoxy-2-methyl-quinazolin-4-amine | | Formula: | C19 H22 N4 O2 | | SMILES: | COc1cc2nc(C)nc(N[CH](C)c3cccc(N)c3)c2cc1OC | | InChi: | InChI=1S/C19H22N4O2/c1-11(13-6-5-7-14(20)8-13)21-19-15-9-17(24-3)18(25-4)10-16(15)22-12(2)23-19/h5-11H,20H2,1-4H3,(H,21,22,23)/t11-/m1/s1 | | Definition date: | 2020-11-06 | | Last modified: | 2021-03-19 | | Release date: | 2021-03-24 | | Identifier: | ~{N}-[(1~{R})-1-(3-aminophenyl)ethyl]-6,7-dimethoxy-2-methyl-quinazolin-4-amine |
|
 | | S3Z | | Name: | ~{N}-[(1~{R})-1-[3-azanyl-5-(trifluoromethyl)phenyl]ethyl]-6,7-dimethoxy-2-methyl-quinazolin-4-amine | | Formula: | C20 H21 F3 N4 O2 | | SMILES: | COc1cc2nc(C)nc(N[CH](C)c3cc(N)cc(c3)C(F)(F)F)c2cc1OC | | InChi: | InChI=1S/C20H21F3N4O2/c1-10(12-5-13(20(21,22)23)7-14(24)6-12)25-19-15-8-17(28-3)18(29-4)9-16(15)26-11(2)27-19/h5-10H,24H2,1-4H3,(H,25,26,27)/t10-/m1/s1 | | Definition date: | 2020-11-06 | | Last modified: | 2021-03-19 | | Release date: | 2021-03-24 | | Identifier: | ~{N}-[(1~{R})-1-[3-azanyl-5-(trifluoromethyl)phenyl]ethyl]-6,7-dimethoxy-2-methyl-quinazolin-4-amine |
|
 | | TG7 | | Name: | 4-[(2-phenylimidazo[1,2-a]pyridin-3-yl)amino]benzene-1,2-dicarboxylic acid | | Formula: | C21 H15 N3 O4 | | SMILES: | c1(nc3ccccn3c1Nc2cc(C(O)=O)c(C(O)=O)cc2)c4ccccc4 | | InChi: | InChI=1S/C21H15N3O4/c25-20(26)15-10-9-14(12-16(15)21(27)28)22-19-18(13-6-2-1-3-7-13)23-17-8-4-5-11-24(17)19/h1-12,22H,(H,25,26)(H,27,28) | | Definition date: | 2020-03-20 | | Last modified: | 2021-03-19 | | Release date: | 2021-03-24 | | Identifier: | 4-[(2-phenylimidazo[1,2-a]pyridin-3-yl)amino]benzene-1,2-dicarboxylic acid |
|
 | | TGM | | Name: | 4-{[2-(2-hydroxyphenyl)imidazo[1,2-a]pyridin-3-yl]amino}benzene-1,2-dicarboxylic acid | | Formula: | C21 H15 N3 O5 | | SMILES: | c1(nc3ccccn3c1Nc2ccc(c(c2)C(O)=O)C(O)=O)c4c(cccc4)O | | InChi: | InChI=1S/C21H15N3O5/c25-16-6-2-1-5-14(16)18-19(24-10-4-3-7-17(24)23-18)22-12-8-9-13(20(26)27)15(11-12)21(28)29/h1-11,22,25H,(H,26,27)(H,28,29) | | Definition date: | 2020-03-20 | | Last modified: | 2021-03-19 | | Release date: | 2021-03-24 | | Identifier: | 4-{[2-(2-hydroxyphenyl)imidazo[1,2-a]pyridin-3-yl]amino}benzene-1,2-dicarboxylic acid |
|
 | | TGV | | Name: | 4-[(2-phenylimidazo[1,2-a]pyrazin-3-yl)amino]benzene-1,2-dicarboxylic acid | | Formula: | C20 H14 N4 O4 | | SMILES: | c2(c(n1ccncc1n2)Nc3cc(C(O)=O)c(C(O)=O)cc3)c4ccccc4 | | InChi: | InChI=1S/C20H14N4O4/c25-19(26)14-7-6-13(10-15(14)20(27)28)22-18-17(12-4-2-1-3-5-12)23-16-11-21-8-9-24(16)18/h1-11,22H,(H,25,26)(H,27,28) | | Definition date: | 2020-03-20 | | Last modified: | 2021-03-19 | | Release date: | 2021-03-24 | | Identifier: | 4-[(2-phenylimidazo[1,2-a]pyrazin-3-yl)amino]benzene-1,2-dicarboxylic acid |
|
 | | U9S | | Name: | (2R,3S)-oxirane-2,3-dicarboxylic acid | | Formula: | C4 H4 O5 | | SMILES: | C(C1C(O1)C(O)=O)(=O)O | | InChi: | InChI=1S/C4H4O5/c5-3(6)1-2(9-1)4(7)8/h1-2H,(H,5,6)(H,7,8)/t1-,2+ | | Synonyms: | cis-2,3-epoxysuccinic acid | | Definition date: | 2020-05-05 | | Last modified: | 2021-03-19 | | Release date: | 2021-03-24 | | Identifier: | (2R,3S)-oxirane-2,3-dicarboxylic acid |
|
 | | UG1 | | Name: | 5-amino-1-(pyridin-4-yl)-1H-imidazole-4-carboxamide | | Formula: | C9 H9 N5 O | | SMILES: | C(c1ncn(c1N)c2ccncc2)(N)=O | | InChi: | InChI=1S/C9H9N5O/c10-8-7(9(11)15)13-5-14(8)6-1-3-12-4-2-6/h1-5H,10H2,(H2,11,15) | | Definition date: | 2020-05-15 | | Last modified: | 2021-03-19 | | Release date: | 2021-03-24 | | Identifier: | 5-amino-1-(pyridin-4-yl)-1H-imidazole-4-carboxamide |
|